Cullinan Associates’s Lam Research LRCX Stock Holding History

Cullinan Associates’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.8M	Sell	64,500 -32,500	-34%	-$7.27M	1.11%	22
2025 Q4	$16.6M	Hold	97,000	–	–	1.13%	20
2025 Q3	$13M	Hold	97,000	–	–	0.85%	30
2025 Q2	$9.44M	Hold	97,000	–	–	0.62%	41
2025 Q1	$7.05M	Hold	97,000	–	–	0.5%	50
2024 Q4	$7.01M	Sell	97,000 -873,000	-90%	-$66.2M	0.45%	47
2024 Q3	$7.04M	Buy	970,000 +873,000	+900%	+$75.9M	0.4%	57
2024 Q2	$10.3M	Hold	97,000	–	–	0.58%	44
2024 Q1	$9.42M	Hold	97,000	–	–	0.53%	48
2023 Q4	$7.6M	Hold	97,000	–	–	0.42%	55
2023 Q3	$6.08M	Hold	97,000	–	–	0.35%	65
2023 Q2	$6.24M	Hold	97,000	–	–	0.34%	71
2023 Q1	$5.14M	Hold	97,000	–	–	0.3%	86
2022 Q4	$4.08M	Hold	97,000	–	–	0.23%	92
2022 Q3	$3.55M	Hold	97,000	–	–	0.22%	95
2022 Q2	$4.13M	Hold	97,000	–	–	0.25%	90
2022 Q1	$5.21M	Hold	97,000	–	–	0.27%	88
2021 Q4	$6.98M	Hold	97,000	–	–	0.36%	77
2021 Q3	$5.52M	Sell	97,000 -300	-0.3%	-$18.3K	0.31%	83
2021 Q2	$6.33M	Sell	97,300 -1,000	-1%	-$63.1K	0.35%	84
2021 Q1	$5.85M	Buy	98,300 +900	+0.9%	+$49K	0.34%	83
2020 Q4	$4.6M	Sell	97,400 -2,600	-3%	-$109K	0.28%	86
2020 Q3	$3.32M	Hold	100,000	–	–	0.21%	98
2020 Q2	$3.23M	Hold	100,000	–	–	0.23%	96
2020 Q1	$2.4M	Hold	100,000	–	–	0.2%	96
2019 Q4	$2.92M	Buy	+100,000	New	+$2.66M	0.2%	97

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cullinan Associates's LRCX Position: Q1 2026 in Review

Cullinan Associates reduced its Lam Research (LRCX) stake by 34% in Q1 2026, selling an estimated $7.27M and leaving 64,500 shares worth $13.8M. The position accounts for 1.11% of the portfolio, ranked #22.

Cullinan Associates first reported a position in LRCX in Q4 2019 and has held it in 26 quarters since. The position peaked at $16.6M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Cullinan Associates held 64,500 shares of Lam Research worth $13.8M as of Q1 2026.
Cullinan Associates sold 32,500 Lam Research shares in Q1 2026, an estimated $7.27M.
Lam Research made up 1.11% of Cullinan Associates's portfolio in Q1 2026, its #22 holding.
Cullinan Associates first reported a position in Lam Research in Q4 2019 and has held it in 26 quarters since.
Cullinan Associates's Lam Research position peaked at $16.6M in Q4 2025.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.